The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
NTM drug discovery: status, gaps and the way forward
Open accessAbstract
Incidence of pulmonary diseases caused by non-tuberculous mycobacteria (NTM), relatives of Mycobacterium tuberculosis, is increasing at an alarming rate, surpassing tuberculosis in many countries. Current chemotherapies require long treatment times and the clinical outcomes are often disappointing. There is an urgent medical need to discover and develop new, more-efficacious anti-NTM drugs. In this review, we summarize the current status of NTM drug development, and highlight knowledge gaps and scientific obstacles in NTM drug discovery. We propose strategies to reduce biological uncertainties and to begin to populate a NTM drug pipeline with attractive leads and drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1×
“Of note, similar to clofazimine which targets type II NADH-quinone oxidoreductase (NDH-2) [51], a key component in the electron transport chain, bedaquiline also targets oxidative phosphorylation via inhibiting ATP synthase [52].”
BackgroundTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
Prevots, D. R., & Marras, T. K. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.10.002 · Cited by 920
Mycobacterium abscessus: a new antibiotic nightmare
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., & Gicquel, B. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr578 · Cited by 799
Haworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210927 · Cited by 785
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740
Bryant, J. M., Grogono, D. M., Greaves, D., Foweraker, J., Roddick, I., Inns, T., Reacher, M., Haworth, C. S., Curran, M. D., Harris, S. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60632-7 · Cited by 694
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
Adjemian, J., Olivier, K. N., Seitz, A. E., Holland, S. M., & Prevots, D. R. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2016oc · Cited by 690
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Bryant, J. M., Grogono, D. M., Rodriguez-Rincon, D., Everall, I., Brown, K. P., Moreno, P., Verma, D., Hill, E., Drijkoningen, J., Gilligan, P., et al. (2016) · Science · doi:10.1126/science.aaf8156 · Cited by 587
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A., Montes de Oca, R., Shea, Y. R., Seitz, A. E., Holland, S. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0310oc · Cited by 582
Eum, S.-Y., Kong, J.-H., Hong, M.-S., Lee, Y.-J., Kim, J.-H., Hwang, S.-H., Cho, S.-N., Via, L. E., & Barry, C. E. (2010) · Chest · doi:10.1378/chest.09-0903 · Cited by 548
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Adams, K. N., Takaki, K., Connolly, L. E., Wiedenhoft, H., Winglee, K., Humbert, O., Edelstein, P. H., Cosma, C. L., & Ramakrishnan, L. (2011) · Cell · doi:10.1016/j.cell.2011.02.022 · Cited by 530
Rao, S. P. S., Alonso, S., Rand, L., Dick, T., & Pethe, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711697105 · Cited by 517
Self-citationClinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Koh, W.-J., Jeon, K., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., Shin, S. J., Huitt, G. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0395oc · Cited by 515
Tahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05708-11 · Cited by 504
The association between sterilizing activity and drug distribution into tuberculosis lesions
Prideaux, B., Via, L. E., Zimmerman, M. D., Eum, S., Sarathy, J., O'Brien, P., Chen, C., Kaya, F., Weiner, D. M., Chen, P.-Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3937 · Cited by 461
Self-citationJarand, J., Levin, A., Zhang, L., Huitt, G., Mitchell, J. D., & Daley, C. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq237 · Cited by 429
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Dartois, V. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3200 · Cited by 388
Self-citationStratified Growth in Pseudomonas aeruginosa Biofilms
Werner, E., Roe, F., Bugnicourt, A., Franklin, M. J., Heydorn, A., Molin, S., Pitts, B., & Stewart, P. S. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.6188-6196.2004 · Cited by 384
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Lenaerts, A., Barry, C. E., & Dartois, V. (2015) · Immunological Reviews · doi:10.1111/imr.12252 · Cited by 362
Self-citationUpdate on pulmonary disease due to non-tuberculous mycobacteria
Stout, J. E., Koh, W.-J., & Yew, W. W. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.03.006 · Cited by 355
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
van Ingen, J., Boeree, M. J., van Soolingen, D., & Mouton, J. W. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.04.001 · Cited by 351
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Wallace, R. J., Brown-Elliott, B. A., McNulty, S., Philley, J. V., Killingley, J., Wilson, R. W., York, D. S., Shepherd, S., & Griffith, D. E. (2014) · Chest · doi:10.1378/chest.13-2538 · Cited by 350
Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
Yano, T., Kassovska-Bratinova, S., Teh, J. S., Winkler, J., Sullivan, K., Isaacs, A., Schechter, N. M., & Rubin, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200501 · Cited by 346
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
Andréjak, C., Nielsen, R., Thomsen, V. Ø., Duhaut, P., Sørensen, H. T., & Thomsen, R. W. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-201772 · Cited by 340
Jeon, K., Kwon, O. J., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., & Koh, W.-J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0704oc · Cited by 336
Pethe, K., Sequeira, P. C., Agarwalla, S., Rhee, K., Kuhen, K., Phong, W. Y., Patel, V., Beer, D., Walker, J. R., Duraiswamy, J., et al. (2010) · Nature Communications · doi:10.1038/ncomms1060 · Cited by 292
Self-citationZhang, Y., Scorpio, A., Nikaido, H., & Sun, Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2044-2049.1999 · Cited by 285
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
Sacksteder, K. A., Protopopova, M., Barry, C. E., Andries, K., & Nacy, C. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.56 · Cited by 269
van Ingen, J., Aksamit, T., Andrejak, C., Böttger, E. C., Cambau, E., Daley, C. L., Griffith, D. E., Guglielmetti, L., Holland, S. M., Huitt, G. A., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00170-2018 · Cited by 264
Gengenbacher, M., Rao, S. P. S., Pethe, K., & Dick, T. (2010) · Microbiology · doi:10.1099/mic.0.033084-0 · Cited by 260
Self-citationLocation of Persisting Mycobacteria in a Guinea Pig Model of Tuberculosis Revealed by R207910
Lenaerts, A. J., Hoff, D., Aly, S., Ehlers, S., Andries, K., Cantarero, L., Orme, I. M., & Basaraba, R. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00276-07 · Cited by 257
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1816 · Cited by 256
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease
Olivier, K. N., Griffith, D. E., Eagle, G., McGinnis, J. P., Micioni, L., Liu, K., Daley, C. L., Winthrop, K. L., Ruoss, S., Addrizzo-Harris, D. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0700oc · Cited by 254
Tuberculosis biomarkers discovery: developments, needs, and challenges
Wallis, R. S., Kim, P., Cole, S., Hanna, D., Andrade, B. B., Maeurer, M., Schito, M., & Zumla, A. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70034-3 · Cited by 241
Prammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Activities of Linezolid against Rapidly Growing Mycobacteria
Wallace, R. J., Brown-Elliott, B. A., Ward, S. C., Crist, C. J., Mann, L. B., & Wilson, R. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.764-767.2001 · Cited by 226
Philley, J. V., Wallace, R. J., Benwill, J. L., Taskar, V., Brown-Elliott, B. A., Thakkar, F., Aksamit, T. R., & Griffith, D. E. (2015) · Chest · doi:10.1378/chest.14-2764 · Cited by 225
Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
Sarathy, J. P., Via, L. E., Weiner, D., Blanc, L., Boshoff, H., Eugenin, E. A., Barry, C. E., & Dartois, V. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02266-17 · Cited by 224
Self-citationMolecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis
Jönsson, B. E., Gilljam, M., Lindblad, A., Ridell, M., Wold, A. E., & Welinder-Olsson, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02592-06 · Cited by 222
Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Koh, W.-J., Moon, S. M., Kim, S.-Y., Woo, M.-A., Kim, S., Jhun, B. W., Park, H. Y., Jeon, K., Huh, H. J., Ki, C.-S., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02503-2016 · Cited by 217
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease
Koh, W.-J., Jeong, B.-H., Kim, S.-Y., Jeon, K., Park, K. U., Jhun, B. W., Lee, H., Park, H. Y., Kim, D. H., Huh, H. J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw724 · Cited by 212
The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages
Roux, A.-L., Viljoen, A., Bah, A., Simeone, R., Bernut, A., Laencina, L., Deramaudt, T., Rottman, M., Gaillard, J.-L., Majlessi, L., et al. (2016) · Open Biology · doi:10.1098/rsob.160185 · Cited by 206
MmpL3 is the flippase for mycolic acids in mycobacteria
Xu, Z., Meshcheryakov, V. A., Poce, G., & Chng, S.-S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700062114 · Cited by 201 · cited 6×
“Several TB actives in development, such as SQ109 (a 1,2ethylenediamine that can target MmpL3 [65,66]), DC-159a (a novel fluoroquinolone), SQ641 (a capuramycin analog), ACH-702 (a new isothiazoloquinolone) and mefloquine (a quinoline used for malaria) are active against some NTM strains [67–71].”
BackgroundInfluentialWallace, R. J., Dukart, G., Brown-Elliott, B. A., Griffith, D. E., Scerpella, E. G., & Marshall, B. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku062 · Cited by 188
Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice
Aly, S., Wagner, K., Keller, C., Malm, S., Malzan, A., Brandau, S., Bange, F., & Ehlers, S. (2006) · The Journal of Pathology · doi:10.1002/path.2055 · Cited by 185
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
Kirchner, S., Fothergill, J. L., Wright, E. A., James, C. E., Mowat, E., & Winstanley, C. (2012) · Journal of Visualized Experiments · doi:10.3791/3857 · Cited by 172
van Ingen, J., Totten, S. E., Helstrom, N. K., Heifets, L. B., Boeree, M. J., & Daley, C. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01505-12 · Cited by 172
In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor
Huitric, E., Verhasselt, P., Andries, K., & Hoffner, S. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00181-07 · Cited by 172
Characterization of biofilm formation by clinical isolates of Mycobacterium avium
Carter, G., Wu, M., Drummond, D. C., & Bermudez, L. E. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05224-0 · Cited by 169
Self-citationβ-Lactamase inhibition by avibactam in Mycobacterium abscessus
Dubée, V., Bernut, A., Cortes, M., Lesne, T., Dorchene, D., Lefebvre, A.-L., Hugonnet, J.-E., Gutmann, L., Mainardi, J.-L., Herrmann, J.-L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku510 · Cited by 164
Oxygen depletion induced dormancy in Mycobacterium smegmatis
Dick, T. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00166-9 · Cited by 162
Self-citationSteed, K. A., & Falkinham, J. O. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.02573-05 · Cited by 160
Prediction of Drug Penetration in Tuberculosis Lesions
Sarathy, J. P., Zuccotto, F., Ho, H., Sandberg, L., Via, L. E., Marriner, G. A., Masquelin, T., Wyatt, P. G., Ray, P. C., & Dartois, V. A. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00051 · Cited by 160
Self-citationThe Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States
Strollo, S. E., Adjemian, J., Adjemian, M. K., & Prevots, D. R. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201503-173oc · Cited by 158
Ojha, A. K., & Hatfull, G. F. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05935.x · Cited by 155
Research Committee of the British Thoracic Society (2001) · Thorax · doi:10.1136/thorax.56.3.167 · Cited by 153
Greendyke, R., & Byrd, T. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00986-07 · Cited by 150
Martiniano, S. L., Wagner, B. D., Levin, A. R., Nick, J. A., Sagel, S. D., & Daley, C. L. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.04.175 · Cited by 150
Sarathy, J., Dartois, V., Dick, T., & Gengenbacher, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02202-12 · Cited by 148
Self-citationField, S. K., & Cowie, R. L. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1482 · Cited by 147
Jarand, J. M., Davis, J. P., Cowie, R. L., Field, S. K., & Fisher, D. A. (2015) · CHEST Journal · doi:10.1378/chest.15-0543 · Cited by 147
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic
Chaisson, R. E., Keiser, P. H., Pierce, M. A., Fessel, W. J., Ruskin, J., Lahart, C. J., Benson, C. A., MEEK, K., Siepman, N. Y., & Craft, J. C. (1997) · AIDS · doi:10.1097/00002030-199703110-00008 · Cited by 145
Rominski, A., Roditscheff, A., Selchow, P., Böttger, E. C., & Sander, P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw466 · Cited by 143
Hoff, D. R., Ryan, G. J., Driver, E., Ssemakulu, C. C., Groote, M. A. D., Basaraba, R. J., & Lenaerts, A. J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017550 · Cited by 142
Rifabutin Is Active against Mycobacterium abscessus Complex
Aziz, D. B., Low, J. L., Wu, M.-L., Gengenbacher, M., Teo, J. W. P., Dartois, V. A., & Dick, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-17 · Cited by 141
Self-citationThe antimicrobial susceptibility of non-tuberculous mycobacteria
Cowman, S. A., Burns, K., Benson, S., Wilson, R., & Loebinger, M. R. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.12.007 · Cited by 140
Differential Antibiotic Susceptibilities of Starved Mycobacterium tuberculosis Isolates
Xie, Z., Siddiqi, N., & Rubin, E. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4778-4780.2005 · Cited by 136
Guillemin, I., Jarlier, V., & Cambau, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2084 · Cited by 132
Yamazaki, Y., Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B. V., Petrofsky, M., Bildfell, R. J., & Bermudez, L. E. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00667.x · Cited by 132
Self-citationLack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus
Maurer, F. P., Bruderer, V. L., Ritter, C., Castelberg, C., Bloemberg, G. V., & Böttger, E. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02448-14 · Cited by 132
Animal model ofMycobacterium abscessuslung infection
Ordway, D. J., Henao-Tamayo, M. I., Smith, E. E., Shanley, C. A., Harton, M. R., Troudt, J. M., Bai, X., Basaraba, R. J., Orme, I. M., & Chan, E. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1007696 · Cited by 132
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases
van Ingen, J., Wagner, D., Gallagher, J., Morimoto, K., Lange, C. G., HAWORTH, C. S., Floto, R. A., Adjemian, J., Prevots, D. R., & Griffith, D. E. (2016) · European Respiratory Journal · doi:10.1183/13993003.01855-2016 · Cited by 132
Thomas, S. R., Ray, A., Hodson, M. E., & Pitt, T. L. (2000) · Thorax · doi:10.1136/thorax.55.9.795 · Cited by 131
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Dupont, C., Viljoen, A. J., Dubar, F., Blaise, M., Bernut, A., Pawlik, A., Bouchier, C., Brosch, R., Guérardel, Y., Lelièvre, J., et al. (2016) · Molecular Microbiology · doi:10.1111/mmi.13406 · Cited by 129
Shen, G., Wu, B.-D., Hu, S.-T., Lin, C.-F., Wu, K.-M., & Chen, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.008 · Cited by 127
Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
Obregón‐Henao, A., Arnett, K. A., Henao-Tamayo, M. I., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00459-15 · Cited by 127
Dupont, C., Viljoen, A. J., Thomas, S. S., Roquet, F., Herrmann, J., Pethe, K., & Kremer, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-17 · Cited by 126
Kaushik, A., Makkar, N., Pandey, P., Parrish, N. M., Singh, U. B., & Lamichhane, G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01158-15 · Cited by 125
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase
Wellington, S., Nag, P. P., Michalska, K., Johnston, S. E., Jedrzejczak, R. P., Kaushik, V. K., Clatworthy, A. E., Siddiqi, N., McCarren, P. R., Bajrami, B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2420 · Cited by 124
Nessar, R., Reyrat, J. M., Murray, A., & Gicquel, B. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr209 · Cited by 123
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
Li, W., Obregón‐Henao, A., Wallach, J. B., North, E. J., Lee, R. E., Jr., Juarrero, M. G., Schnappinger, D., & Jackson, M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-16 · Cited by 123
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Yang, B., Jhun, B. W., Moon, S. M., Lee, H. J., Park, H. Y., Jeon, K., Kim, D. H., Kim, S., Shin, S. J., Daley, C. L., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02052-16 · Cited by 122
Studies on the Effect of Starvation on Mycobacteria
Nyka, W. M. (1974) · Infection and Immunity · doi:10.1128/iai.9.5.843-850.1974 · Cited by 121
In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
Lerat, I., Cambau, E., Bettoni, R. R. D., Gaillard, J., Jarlier, V., Truffot-Pernot, C., & Véziris, N. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit614 · Cited by 121
Nontuberculous Mycobacteria in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis
Park, I., & Olivier, K. N. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1546751 · Cited by 119
Meier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Ferro, B. E., Meletiadis, J., Wattenberg, M., de Jong, A., van Soolingen, D., Mouton, J. W., & van Ingen, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-15 · Cited by 115
Hurst-Hess, K., Rudra, P., & Ghosh, P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01347-17 · Cited by 115
In Vitro Activity of Linezolid against Slowly Growing Nontuberculous Mycobacteria
Brown‐Elliott, B. A., Crist, C. J., Mann, L. B., Wilson, R. W., & Wallace, R. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1736-1738.2003 · Cited by 106
Lefebvre, A.-L., Moigne, V. L., Bernut, A., Veckerlé, C., Compain, F., Herrmann, J., Kremer, L., Arthur, M., & Mainardi, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02440-16 · Cited by 106
“Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria
Shahraki, A. H., Heidarieh, P., Bostanabad, S. Z., Khosravi, A. D., Hashemzadeh, M., Khandan, S., Biranvand, M., Schraufnagel, D. E., & Mirsaeidi, M. S. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.001 · Cited by 104
van Ingen, J., van der Laan, T., Dekhuijzen, R. P. N., Boeree, M. J., & van Soolingen, D. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.023 · Cited by 104
Clarithromycin Minimal Inhibitory and Bactericidal Concentrations against Mycobacterium avium
Heifets, L. B., Lindholm-Levy, P. J., & Comstock, R. D. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.856 · Cited by 100
Szumowski, J. D., Adams, K. N., Edelstein, P. H., & Ramakrishnan, L. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_300 · Cited by 99
In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex
Brown‐Elliott, B. A., Philley, J. V., Griffith, D. E., Thakkar, F., & Wallace, R. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01798-16 · Cited by 97
Rose, S. J., Babrak, L. M., & Bermudez, L. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128772 · Cited by 94
Alexander, D. C., Vasireddy, R., Vasireddy, S., Philley, J. V., Brown‐Elliott, B. A., Perry, B. J., Griffith, D. E., Benwill, J. L., Cameron, A. D. S., & Wallace, R. J. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02087-16 · Cited by 93
Boromycin Kills Mycobacterial Persisters without Detectable Resistance
Moreira, W., Aziz, D. B., & Dick, T. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00199 · Cited by 92
Self-citationBernut, A., Herrmann, J., Ordway, D. J., & Kremer, L. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00100 · Cited by 92
In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria
Brown‐Elliott, B. A., & Wallace, R. J. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00274-17 · Cited by 90
In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China
Pang, Y., Zheng, H., Tan, Y., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02627-16 · Cited by 88
Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications
Sapriel, G., Konjek, J., Orgeur, M., Bouri, L., Frézal, L., Roux, A., Dumas, É., Brosch, R., Bouchier, C., Brisse, S., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-2448-1 · Cited by 85
Rominski, A., Selchow, P., Becker, K., Brülle, J. K., Molin, M. D., & Sander, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx125 · Cited by 84
Halloum, I., Viljoen, A. J., Khanna, V., Craig, D., Bouchier, C., Brosch, R., Coxon, G. D., & Kremer, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02509-16 · Cited by 83
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex
Lavollay, M., Dubée, V., Heym, B., Herrmann, J., Gaillard, J., Gutmann, L., Arthur, M., & Mainardi, J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12405 · Cited by 82
Mefloquine Is Active In Vitro and In Vivo againstMycobacterium aviumComplex
Bermudez, L. E., Kolonoski, P., Wu, M., Aralar, P., Inderlied, C. B., & Young, L. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1870 · Cited by 82
Self-citationRaju, R. M., Raju, S. M., Zhao, Y., & Rubin, E. J. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151643 · Cited by 82
Miranda-CasoLuengo, A. A., Staunton, P. M., Dinan, A. M., Lohan, A. J., & Loftus, B. J. (2016) · BMC Genomics · doi:10.1186/s12864-016-2868-y · Cited by 81
Haley, C. L., Colmer‐Hamood, J. A., & Hamood, A. N. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-181 · Cited by 81
Bactericidal and intracellular activity of β-lactams againstMycobacterium abscessus
Lefebvre, A.-L., Dubée, V., Cortès, M., Dorchêne, D., Arthur, M., & Mainardi, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw022 · Cited by 81
Larsson, C., Luna, B. M., Ammerman, N. C., Maïga, M., Agarwal, N., & Bishai, W. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037516 · Cited by 80
Walker, J. T., Moore, G., Collins, S., Parks, S. R., Garvey, M. I., Lamagni, T. L., Smith, G., Dawkin, L., Goldenberg, S. D., & Chand, M. A. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.04.014 · Cited by 80
Yang, T., Moreira, W., Nyantakyi, S. A., Chen, H., Aziz, D. B., Go, M., & Dick, T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01530 · Cited by 79
Self-citationKozikowski, A. P., Onajole, O. K., Stec, J., Dupont, C., Viljoen, A. J., Richard, M., Chaira, T., Lun, S., Bishai, W. R., Raj, V. S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00582 · Cited by 77
Mycobacterium avium uses apoptotic macrophages as tools for spreading
Early, J. V., Fischer, K. A., & Bermudez, L. E. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2010.12.004 · Cited by 76
Genes Required for Intrinsic Multidrug Resistance in Mycobacterium avium
Philalay, J. S., Palermo, C. O., Hauge, K. A., Rustad, T. R., & Cangelosi, G. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3412-3418.2004 · Cited by 76
Singh, S., Bouzinbi, N., Chaturvedi, V., Godreuil, S., & Kremer, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12780 · Cited by 74
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies
Mougari, F., Bouziane, F., Crockett, F., Nessar, R., Chau, F., Véziris, N., Sapriel, G., Raskine, L., & Cambau, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00943-16 · Cited by 74
Kaushik, A., Gupta, C., Fisher, S., Story‐Roller, E., Galanis, C., Parrish, N. M., & Lamichhane, G. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0234 · Cited by 72
Nie, W., Duan, H., Huang, H., Lu, Y., Bi, D., & Chu, N. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.02.014 · Cited by 71
Bange, F., Brown, B. A., Smaczny, C., Wallace, R. J., & Böttger, E. C. (2001) · Clinical Infectious Diseases · doi:10.1086/320525 · Cited by 71
Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus
Kim, T. S., Choe, J. H., Kim, Y. J., Yang, C., Kwon, H., Jeong, J., Kim, G., Park, D. E., Jo, E., Cho, Y. L., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02752-16 · Cited by 71
Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
Low, J. L., Wu, M.-L., Aziz, D. B., Laleu, B., & Dick, T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01539 · Cited by 71
Self-citationComparative Genomics of the Dormancy Regulons in Mycobacteria
Gerasimova, A. V., Kazakov, A. E., Arkin, A. P., Dubchak, I. L., & Gelfand, M. S. (2011) · Journal of Bacteriology · doi:10.1128/jb.00179-11 · Cited by 69
Huang, C., Chen, J., Hu, S.-T., Huang, W., Lee, Y.-C., Huang, C.-C., & Shen, G. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.021 · Cited by 65
Wu, M.-L., Gengenbacher, M., & Dick, T. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00947 · Cited by 62
Self-citationRamón‐García, S., Ng, C., Jensen, P. R., Dosanjh, M., Burian, J., Morris, R. P., Folcher, M., Eltis, L. D., Grzesiek, S., Nguyen, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.516385 · Cited by 59
Pryjma, M., Burian, J., Kuchinski, K. S., & Thompson, C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01353-17 · Cited by 58
In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria
Aguilar-Ayala, D. A., Cnockaert, M. C., André, E., Andries, K., González-y-Merchand, J. A., Vandamme, P. A. R., Palomino, J. C., & Martin, A. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000537 · Cited by 57
Oh, C.-T., Moon, C., Park, O. K., Kwon, S.-H., & Jang, J. W. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku024 · Cited by 55
Zweijpfenning, S. M. H., Kops, S. E. P., Magis-Escurra, C., Boeree, M. J., van Ingen, J., & Hoefsloot, W. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.08.031 · Cited by 55
ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal
Lounis, N., Gevers, T., Van Den Berg, J., Vranckx, L., & Andries, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-09 · Cited by 54
Rominski, A., Schulthess, B., Müller, D. M., Keller, P. M., & Sander, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx284 · Cited by 51
Choi, G. E., Min, K.-N., Won, C.-J., Jeon, K., Shin, S. J., & Koh, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00685-12 · Cited by 50
Mukherjee, D., Zou, H., Liu, S., Beuerman, R. W., & Dick, T. (2016) · Future Microbiology · doi:10.2217/fmb-2015-0015 · Cited by 50
Self-citationAly, S., Laskay, T., Mages, J., Malzan, A., Lang, R., & Ehlers, S. (2007) · The Journal of Pathology · doi:10.1002/path.2185 · Cited by 46
In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria
Dubuisson, T., Bogatcheva, E., Krishnan, M. Y., Collins, M., Einck, L., Nacy, C. A., & Reddy, V. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq372 · Cited by 46
The biology of environmental mycobacteria
Falkinham, J. O. (2009) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2009.00054.x · Cited by 46
Studies on the gaseous content of tuberculous cavities.
Haapanen, J., Kass, I., Gensini, G. F., & Middlebrook, G. (1959) · PubMed · doi:10.1164/arrd.1959.80.1p1.1 · Cited by 44
The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent
Deshpande, D., Srivastava, S., Chapagain, M. L., Lee, P. S., Cirrincione, K. N., Pasipanodya, J. G., & Gumbo, T. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx306 · Cited by 44
Zhang, Z., Lu, J. L., Liu, M., Wang, Y., Zhao, Y., & Pang, Y. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.12.003 · Cited by 43
Huang, C.-C., Wu, M., Chen, H., & Huang, W. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.05.001 · Cited by 41
Self-citationGuinn, K. M., & Rubin, E. J. (2017) · mBio · doi:10.1128/mbio.01910-17 · Cited by 40
Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
Mukherjee, D., Wu, M.-L., Teo, J. W. P., & Dick, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01298-17 · Cited by 37
Self-citationCabrera, L. V., Brown‐Elliott, B. A., Wallace, R. J., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00763-06 · Cited by 35
Reactive dirty fragments: implications for tuberculosis drug discovery
Gopal, P., & Dick, T. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.06.015 · Cited by 35
Self-citationDraft Genome Sequence of Mycobacterium abscessus Bamboo
Yee, M., Klinzing, D. C., Wei, J.-R., Gengenbacher, M., Rubin, E. J., & Dick, T. (2017) · Genome Announcements · doi:10.1128/genomea.00388-17 · Cited by 34
Self-citationAssociation of rpoB mutations with rifampicin resistance in Mycobacterium avium
Obata, S., Zwolska, Z., Toyota, E., et al. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.09.015 · Cited by 30
Sun, Z., Scorpio, A., & Zhang, Y. (1997) · Microbiology · doi:10.1099/00221287-143-10-3367 · Cited by 28
Carrère‐Kremer, S., Blaise, M., Singh, V. K., Alibaud, L., Tuaillon, É., Halloum, I., van de Weerd, R., Guérardel, Y., Drancourt, M., Takiff, H. E., et al. (2015) · Molecular Microbiology · doi:10.1111/mmi.12992 · Cited by 24
Kim, S., Subhadra, B., Whang, J., Back, Y. W., Bae, H. S., Kim, H., & Choi, C. H. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx107 · Cited by 24
DprE1, a new taxonomic marker in mycobacteria
Incandela, M. L., Perrin, E., Fondi, M., Ribeiro, A., Mori, G., Moiana, A., Gramegna, M., Fani, R., Riccardi, G., & Pasca, M. R. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12246 · Cited by 17
Treatment of Pulmonary Nontuberculous Mycobacterial Infections: Many Questions Remain
Daley, C. L., & Glassroth, J. L. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201311-399ed · Cited by 17
Molina-Torres, C. A., Ocampo‐Candiani, J., Rendón, A., Pucci, M. J., & Cabrera, L. V. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01603-09 · Cited by 15
Cynamon, M. H., Jureller, J., Desai, B., Ramachandran, K., Sklaney, M. R., & Grossman, T. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00743-12 · Cited by 15
Drapal, M., Wheeler, P. R., & Fraser, P. D. (2016) · Microbiology · doi:10.1099/mic.0.000325 · Cited by 13
Tuberculosis Drug Discovery: Issues, Gaps and the Way Forward
Dartois, V. A., Leong, F. J., & Dick, T. (2009) · Wiley eBooks · doi:10.1002/9783527626816.ch21 · Cited by 11
Self-citationAnimal Models of Non-Tuberculous Mycobacterial Infections
Chan, E. D., & Bai, X. (2016) · Mycobacterial Diseases · doi:10.4172/2161-1068.1000216 · Cited by 9
TB Drug Discovery from Target Identification to Proof of Concept Studies
Dick, T., Dartois, V. A., Keller, T. H., & Matter, A. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch40 · Cited by 3
Self-citation
Cited by
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Johansen, M. D., Herrmann, J.-L., & Kremer, L. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0331-1 · Cited by 822
Gopalaswamy, R., Shanmugam, S., Mondal, R., & Subbian, S. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00667-6 · Cited by 350
Luthra, S., Rominski, A., & Sander, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02179 · Cited by 260
Pereira, A. C., Ramos, B., Reis, A. C., & Cunha, M. V. (2020) · Microorganisms · doi:10.3390/microorganisms8091380 · Cited by 101
A Mycobacterial Systems Resource for the Research Community
Judd, J. A., Canestrari, J., Clark, R., Joseph, A., Lapierre, P., Lasek-Nesselquist, E., Mir, M., Palumbo, M., Smith, C., Stone, M., et al. (2021) · mBio · doi:10.1128/mbio.02401-20 · Cited by 45
“Other mycobacteria, including M. abscessus , M. avium , M. kansasii , M. leprae , and M. ulcerans , also have a substantial disease burden, especially in immunocompromised patients (14 – 16).”
Background
Metadata
- Authors
- Wu, M.-L., Aziz, D. B., Dartois, V., & Dick, T.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 23
- Issue
- 8
- Pages
- 1502-1519
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2796455598
- Cited by
- 276
- References
- 170
- FWCI
- 19.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.